Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Hui‐Chuan Sun et al.|The Lancet Oncology|2023Cited by 243
Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathwayJing Zhao, Jieer Ying|Frontiers in Pharmacology|2023Cited by 10
A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cellsXiaoqing Guan, Jieer Ying|PeerJ|2023Cited by 3
Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 StudyLi J, Yi Ba, Rongbo Lin et al.|Clinical Colorectal Cancer|2024Cited by 0